BioMark Diagnostics Inc.
BioMark Diagnostics Inc.
01/07/2024 | Press release | Distributed by Public on 01/07/2024 08:15
A Day To Honour Dr. Daniel Sitar: Fellowship of the Society of Pharmacology and Therapeutics
Today is a day to honour Dr Daniel Sitar: Fellowship Canadian Society of Pharmacology and Therapeutics
Daniel Sitar
BScPharm, MSc, PhD, FGSA,FCP, Professor Emeritus, Rady Faculty of Health Sciences - College of Medicine (Departments of Internal Medicine, Pharmacology and Therapeutics, Pediatrics and Child Health), College of Pharmacy, and Centre on Aging, University of
Manitoba.
Dr. Sitar completed his university degrees at the University of Manitoba. Subsequently, he was an MRC Postdoctoral Fellow in the Department of Pharmacology, University of Minnesota. Dr. Sitar then accepted academic positions at McGill University in 1973 in the Division of Experimental Medicine (Clinical Pharmacology Section), and in the Department of Pharmacology and Therapeutics, where he was appointed a Monat Scholar.
In 1978, Dr. Sitar was recruited back to the University of Manitoba to the Department of Internal Medicine (Clinical Pharmacology) and the Department of Pharmacology and Therapeutics, where he participated in the development of the first Geriatric Clinical Pharmacology Research Program in Canada.
Dr. Sitar served as Head of the Department of Pharmacology and Therapeutics from 1999 until 2008. His research area can broadly be described as drug disposition and effects at extremes of age, and encompasses both basic and clinical studies. From 1989-90 he was appointed Rosenstadt Professor at the University of Toronto in the Faculty of Pharmacy.
Dr. Sitar has served on many research grant and advisory panels in various capacities, both in Canada and in the USA. He has served on several Editorial Boards of scientific research journals, including terms as Associate Editor and then Editor in Chief of the Journal of Clinical Pharmacology.
Dr. Sitar's research contributions have been recognized by a number of awards in Canada, including the Piafsky Young investigator Award, and the Senior Investigator Award from the Canadian Society for Clinical Pharmacology.
He is also a recipient of the Senior Scientist Award from the Pharmacological Society of Canada. In the USA, his research has been recognized by Fellowship awards from the Gerontological Society of America and the American College of Clinical Pharmacology.
Share this post:
SearchSearch
Categories
CategoriesSelect Category Articles and Information NewsArchives
ArchivesSelect Month July 2024 (1) June 2024 (1) May 2024 (3) April 2024 (2) March 2024 (1) February 2024 (3) January 2024 (2) December 2023 (3) November 2023 (6) September 2023 (3) August 2023 (3) July 2023 (1) June 2023 (4) May 2023 (2) April 2023 (1) March 2023 (4) February 2023 (4) January 2023 (2) December 2022 (1) November 2022 (2) October 2022 (2) September 2022 (4) August 2022 (3) July 2022 (1) June 2022 (2) May 2022 (3) April 2022 (2) June 2021 (3) May 2021 (4) April 2021 (3) March 2021 (8) February 2021 (5) January 2021 (2) October 2020 (1) September 2020 (3) August 2020 (2) July 2020 (2) June 2020 (5) March 2020 (4) February 2020 (1) January 2020 (1) December 2019 (3) November 2019 (3) August 2019 (4) June 2019 (2) May 2019 (4) April 2019 (4) March 2019 (6) November 2018 (1) October 2018 (2) September 2018 (2) April 2018 (1) February 2018 (2) January 2018 (2) December 2017 (2) November 2017 (1) October 2017 (2) September 2017 (1) June 2017 (2) May 2017 (2) March 2017 (1) February 2017 (1) November 2016 (1) July 2016 (1) June 2016 (4) March 2016 (3) February 2016 (3) September 2015 (7) August 2015 (4) July 2015 (2) June 2015 (1) May 2015 (4) April 2015 (4) March 2015 (4) February 2015 (6) January 2015 (7) December 2014 (6) November 2014 (7) October 2014 (1) September 2014 (7) July 2014 (11)Sign up for the latest Biomark news
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Submit
Investors